Magnesium Infusion for Acute Laryngospasm Treatment
No, magnesium sulfate infusion should NOT be used to break an acute laryngospasm. While magnesium has been studied for prevention of laryngospasm, it is not included in the established treatment algorithm for acute laryngospasm and has no role in emergency management.
The Evidence-Based Treatment Algorithm
The Difficult Airway Society guidelines 1 provide a clear, stepwise approach to treating acute laryngospasm:
Immediate Management Steps:
- Call for help
- Apply CPAP with 100% oxygen using reservoir bag and facemask while maintaining upper airway patency
- Larson's manoeuvre: Apply deep pressure in the "laryngospasm notch" between the posterior mandible and mastoid process while performing jaw thrust
- If persistent/desaturating: Propofol 1-2 mg/kg IV (larger doses needed for severe laryngospasm with total cord closure)
- If worsening hypoxia continues: Suxamethonium 1 mg/kg IV for immediate cord relaxation
- Without IV access: Suxamethonium IM (2-4 mg/kg), intralingual (2-4 mg/kg), or intraosseous (1 mg/kg)
- Atropine for bradycardia if needed
- Surgical airway in extremis
Why Magnesium Is NOT a Treatment Option
The critical distinction: Magnesium is mentioned only as a preventive adjunct, not as acute treatment 1. The guidelines explicitly state that "other adjuncts that have been used to prevent laryngospasm include intravenous lidocaine, doxapram, magnesium, and ketamine" 1.
The FDA Label Concerns
The magnesium sulfate FDA label 2 actually warns that respiratory paralysis is a potential hazard at high magnesium levels (10 mEq/L), with reflexes becoming absent at this concentration. This makes magnesium particularly inappropriate for treating an acute airway emergency where respiratory function is already compromised.
Research Evidence Limitations
The research evidence 3, 4, 5, 6, 7 exclusively examines magnesium for prevention when given preoperatively or intraoperatively:
- A 2024 meta-analysis 3 showed magnesium reduced laryngospasm rates by 6% when given prophylactically (primarily with local administration)
- Studies administered magnesium 15-20 minutes before anticipated events 6, 7, not during acute episodes
- One study 4 found no benefit for prevention, and none examined acute treatment
The mechanism matters: Magnesium's proposed benefit relates to CNS depression and muscle relaxation that develops over time with therapeutic serum levels (3-6 mg/100 mL for seizure control 2). This is fundamentally different from the immediate muscle relaxation needed to break laryngospasm.
Critical Clinical Pitfalls
Time is tissue: Laryngospasm can progress to hypoxic cardiac arrest and death 1. The guideline algorithm prioritizes interventions with immediate effect:
- CPAP and Larson's manoeuvre work within seconds
- Propofol acts within 30-60 seconds
- Suxamethonium provides relaxation within 60 seconds
Attempting magnesium infusion would waste precious time during a life-threatening emergency. The FDA label 2 specifies that magnesium must be diluted and administered slowly to avoid hypermagnesemia—completely incompatible with emergency management.
The Bottom Line
Follow the established DAS algorithm 1: Progress rapidly through CPAP/Larson's manoeuvre → propofol → suxamethonium if laryngospasm persists or oxygen saturation falls. Magnesium has no role in breaking acute laryngospasm and could delay life-saving interventions. If you want to use magnesium, consider it only as a prophylactic measure given 15-20 minutes before extubation in high-risk patients, not as emergency treatment.